Loading insider details...
Beta
Latest Form 4 (Jun 10, 2026): Grant/Award of 15,200 RAPP shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 10, 2026 | Rapport Therapeutics, Inc. (RAPP) | Grant/Award | 15,200 | n/a |
| May 14, 2026 | Alto Neuroscience, Inc. (ANRO) | Grant/Award | 10,958 | n/a |
| Jan 6, 2026 | Alto Neuroscience, Inc. (ANRO) | Grant/Award | 3,806 | $45.0K |
| Aug 14, 2025 | Alto Neuroscience, Inc. (ANRO) | Grant/Award | 30,574 | n/a |
| Jun 18, 2025 | Rapport Therapeutics, Inc. (RAPP) | Grant/Award | 10,925 | n/a |
| Nov 7, 2024 | Rapport Therapeutics, Inc. (RAPP) | Grant/Award | 29,756 | n/a |
| Jan 23, 2024 | Cerevel Therapeutics Holdings, Inc. (CERE) | Grant/Award | 87,573 | n/a |